Roundtable Discussion: Utilizing Biomarkers to Guide Patient Selection, Predict Responses & Improve Safety
- Exploring predictive patient and donor biomarkers to determine the cell therapy modalities best suited for individual patients and disease contexts
- Identifying pre-infusion and on-treatment biomarker signals to understand response dynamics and guide clinical decision making
- Evaluating immune fitness and safety related biomarkers to identify patients at risk, anticipate challenges, and enhance therapeutic outcomes